Analyst Ranking
Top 14%
#687 out of 5087 analysts
Average Return
+18.55%
Win Rate
74%26 out of 35
Risk vs Reward
Poor
Good

Subbu Nambi's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Natera IncNTRA
+176.34%$60.27$166.55
2023-12-14 -
2024-12-13
Strong Buy
Guardant Health IncGH
+119.18%$42.44$93.02
2025-02-24 -
2025-10-31
Strong Buy
Tempus Ai IncTEM
+93.23%$46.50$89.85
2024-12-09 -
2025-10-31
Strong Buy
Guardant Health IncGH
+76.11%$28.88$50.86
2024-06-28 -
2025-06-27
Strong Buy
Cryoport IncCYRX
+64.71%$5.61$9.24
2025-04-16 -
2025-10-31
Strong Buy

Subbu Nambi's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Genedx Holdings CorpWGS
2Strong Buy$170.00+24.17%Maintains
5 days ago
Adaptive Biotechnologies CorpADPT
1Strong Buy$20.00+15.21%Initiates Coverage On
a month ago
Tempus Ai IncTEM
3Strong Buy$95.00+5.73%Maintains
a month ago
Guardant Health IncGH
3Strong Buy$67.00-27.97%Maintains
a month ago
Caris Life Sciences IncCAI
2Strong Buy$36.00+19.68%Maintains
3 months ago
Danaher CorpDHR
2Strong Buy$250.00+16.07%Reiterates
3 months ago
Neogen CorpNEOG
3Strong Buy$10.00+62.07%Maintains
4 months ago
Illumina IncILMN
3Strong Buy$114.00-7.72%Maintains
6 months ago
Twist Bioscience CorpTWST
2Strong Buy$50.00+52.02%Reiterates
6 months ago
Cryoport IncCYRX
1Strong Buy$10.00+8.23%Reiterates
7 months ago
Exact Sciences CorpEXAS
2Strong Buy$60.00-7.25%Reiterates
7 months ago
Veracyte IncVCYT
3Strong Buy$37.00+2.55%Maintains
7 months ago
Natera IncNTRA
2Strong Buy$200.00+0.54%Maintains
10 months ago
Bruker CorpBRKR
1Strong Buy$72.00+84.90%Initiates Coverage On
10 months ago
Sophia Genetics SaSOPH
1Strong Buy$6.00N/AInitiates Coverage On
a year ago
Nautilus Biotechnology IncNAUT
1Strong Buy$6.00N/AInitiates Coverage On
a year ago
Castle Biosciences IncCSTL
1Strong Buy$25.00N/AInitiates Coverage On
2 years ago
Myriad Genetics IncMYGN
1Strong Buy$23.00N/AInitiates Coverage On
2 years ago
10x Genomics IncTXG
1Strong Buy$60.00N/AInitiates Coverage On
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.